CDK4 and cancer: Somatic copy number deletion of the CDKN2A gene is a transformed cell-specific event, which prompted scientists to study whether disruption of the CDKN2A deletion-related feedback regulatory loop may overcome the resistance of P16-inactivated cancer cells to CDK4 inhibitors.